Product Information

BUMETANIDE 2 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1767 per EA under NDC 72603029902. Its NADAC has been published 43 times since Oct 29, 2025.

FDA first approved this application on Apr 24, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the bumetanide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BUMETANIDE 2 MG TABLET

bumetanide
$0.1767per EA
High Outlier

Strength

2 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603029902

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BUMETANIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074225

FDA Approved

4/24/1995

TE Code

AB

On Market Since

9/1/2025

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for BUMETANIDE 2 MG TABLET has been published 43 times since Oct 29, 2025, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1767 per EA
All-time high$0.2198 (Nov 12, 2025)
All-time low$0.1717 (Jul 22, 2026)
52-week high$0.2198
52-week low$0.1717
Median price$0.1826
Average price$0.1845
Largest weekly change-11.7% (Nov 19, 2025)
Weeks tracked43
Tracking sinceOct 29, 2025

Price History

1W

+3.0%

1M

+3.0%

3M

-1.8%

6M

-5.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-19.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUMETANIDE 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1767 per EA (NDC 72603029902), effective Aug 19, 2026.

How has the price of BUMETANIDE 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 19.6%. It has been tracked across 43 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?

Since Oct 29, 2025, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.1717 (Jul 22, 2026) to a high of $0.2198 (Nov 12, 2025), with a median of $0.1826 per EA.

Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUMETANIDE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUMETANIDE 2 MG TABLET?

BUMETANIDE 2 MG TABLET (NDC 72603029902) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.